Credit: Getty Images. Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of ...

Although previous research has demonstrated the superiority of various herbal medicines over comparator therapies for atopic dermatitis, there are insufficient data to warrant any specific ...

Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their ...

Atopic dermatitis is one of the most common chronic inflammatory skin diseases worldwide and is also the most common form of eczema. Although infants and children are most often affected, adults can ...

This review focuses on the pathogenesis, influencing factors, limitations of current treatments, and recent advances in the application of natural extracts for atopic dermatitis (AD). The authors ...

Key opinion leaders provide a concise overview of the atopic dermatitis (AD) treatment landscape, focusing on the role of topical therapy, and highlight the current unmet needs in AD management. Stay ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Shastry is an assistant professor of dermatology at Northwestern Feinberg School of Medicine in Chicago. The information here represents her knowledge and experience as a medical professional. She was ...

Alphyn, a clinical-stage dermatology company developing the first Multi-Target Therapeutics (R) drug platform, announced today that it has completed enrollment in its CLEAR-AD1 Phase 2b clinical trial ...

The strong interest in participating in this Phase 2 trial reflects the urgent need for innovative solutions in atopic dermatitis and the excitement surrounding bosakitug and the potential role of ...